Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

COVID-19: Threats and opportunities

Covid-19 is going to have a huge impact on for-profit healthcare services. In the first of a two-part report, we look at what that will be at a sector and country level. Digital health looks like being a winner, Ping An claims online consultations are up tenfold, with the spectre of a crash in elective procedures hanging over for-profit hospitals and specialist outpatient chains. We also look at the likely impact on M&A.  The second part of this report, focussing on the care sector, will be published next week.

Investors for Health opens door to all serious emerging market investors

All emerging market health-care investors are welcome to join Investors for Health (I4H), a newish community of 30+ investors including development banks, private equity, venture capital and impact funds. The group aims to jointly focus on private healthcare development in emerging markets with a focus on equity and alignment with universal healthcare cover. It next meets at HBI 2020, April 20-22, London. Its formation reflects a quiet revolution in the role of for-profit healthcare and its importance in bridging the World Health Organisation's estimated $686bn funding gap in low-and-middle-income countries to achieve the United Nation’s Sustainable Development Goal #3 (“Ensure healthy lives and promote well-being for all at all ages”).

SRL shifts focus to B2C as minority sale stalls

Fortis-owned Indian lab chain SRL says that after the last two years of "stagnant expansion" it has started to open more blood collection points in a shift to the B2C segment. The company remains tight-lipped about the ongoing minority sale process.

Dr Lal Pathlabs acquires two labs

India's largest diagnostics chain by revenue, NSE-listed Dr Lal Pathlabs, is acquiring two pathological laboratories for a total of around $1m (€900m).

Find Us